United States · Who invested in NeuroGastrx?
NeuroGastrx's investors include OrbiMed, 5AM Ventures, Vivo Capital, Samsara BioCapital and RTW Investments LLC, and 1 more on record.
20172018201920202021
$45MSeries A$60MSeries B
United States · Series B startup
Who invested in NeuroGastrx
Funding summaryUpdated 26 Oct 2026
$105Mraised across 2 rounds since 2017, from 2 sources
$45MSeries A$60MSeries B
- Latest round
- Series B, $60MAug 2021
- Step-upi
- 1.3×
- Investors
- 6
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $45M Jan 2017
- Biggest round
- $60M Series B · Aug 2021
- Between rounds
- 4.6 years from the last two
The rounds
- Aug 2021Series B$60M3 new2 returning
Source recordedSEC filing: $60M sold, first sale Jun 2021
- Jan 2017
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2017Series B2021
OrbiMed
5AM Ventures
Vivo Capital
Samsara BioCapital
RTW Investments LLC
venBio Partners
OrbiMed5AM VenturesVivo CapitalSamsara BioCapitalRTW Investments LLCvenBio PartnersEveryone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about NeuroGastrx
How much has NeuroGastrx raised?
NeuroGastrx has raised $105M across 2 rounds since 2017.
When did NeuroGastrx last raise?
NeuroGastrx's most recent round was a Series B of $60M in Aug 2021.
What was NeuroGastrx's biggest round?
Its most recent round, $60M in Aug 2021, is also its largest on record.
Who backed NeuroGastrx first?
NeuroGastrx's first round on record, in Jan 2017, was backed by OrbiMed, 5AM Ventures and venBio Partners.
What stage is NeuroGastrx at?
NeuroGastrx's latest named round is a Series B, in Aug 2021.
Where is NeuroGastrx based?
NeuroGastrx is based in the United States.
Companies like NeuroGastrx
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.